Molecular pharmacology of the four histamine receptors

Advances in Experimental Medicine and Biology

Volumn 709, Issue , 2010, Pages 11-19

  Bongers, Gerold ^b   De Esch, Iwan ^b   Leurs, Rob ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (AMIDINOTHIO)ETHYL]GUANIDINE; 4 METHYLHISTAMINE; 6 (3 CYCLOBUTYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPIN 7 YLOXY) N METHYLNICOTINAMIDE; A 423579; ALPHA METHYLHISTAMINE; AMTHAMINE; ANTIHISTAMINIC AGENT; BURIMAMIDE; CIMETIDINE; CLOBENPROPIT; CLOPIDOGREL; DIMAPRIT; FEXOFENADINE; HISTAMINE; HISTAMINE AGONIST; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE H4 RECEPTOR; IMMEPIP; IMMETHRIDINE; MEPYRAMINE; METHIMEPIP; METOPROLOL TARTRATE; QUETIAPINE; RANITIDINE; THIOPERAMIDE; THYMOXIDIETHYLAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC REACTION; ALLERGIC RHINITIS; ANAPHYLACTIC SHOCK; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION; SKIN IRRITATION;

EID: 79960703085     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8056-4_2     Document Type: Review

References (88)

1. Dale HH, Laidlaw PP. J Physiol 1910; 41:318-344.
2. Bovet D, Staub AM. Comp rend Soc Biol 1937; (124):547.
3. Ash AS, Schild HO. Receptors mediating some actions of histamine. Br J Pharmacol Chemother 1966; 27(2):427-439.
4. Black JW, Duncan WA, Durant CJ et al. Definition and antagonism of histamine H2-receptors. Nature 1972; 236(5347):385-390.
5. Arrang JM, Garbarg M, Schwartz JC. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983; 302(5911):832-837. (Pubitemid 13125123)
6. Arrang JM, Garbarg M, Lancelot JC et al. Highly potent and selective ligands for histamine H3-receptors. Nature 1987; 327(6118):117-123. (Pubitemid 17062756)
7. Zhu Y, Michalovich D, Wu H et al. Cloning, expression and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 2001; 59(3):434-441. (Pubitemid 32179920)
8. Nguyen T, Shapiro DA, George SR et al. Discovery of a novel member of the histamine receptor family. Mol Pharmacol 2001; 59(3):427-433. (Pubitemid 32179919)
9. Liu C, Ma X, Jiang X et al. Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. Mol Pharmacol 2001; 59(3):420-426. (Pubitemid 32179918)
10. Morse KL, Behan J, Laz TM et al. Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 2001; 296(3):1058-1066. (Pubitemid 32187382)
11. Oda T, Morikawa N, Saito Y et al. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000; 275(47):36781-36786. (Pubitemid 32002087)
12. Wise A, Gearing K, Rees S. Target validation of G-protein coupled receptors. Drug Discov Today 2002; 7(4):235-246. (Pubitemid 34143072)
13. Service RF. Surviving the blockbuster syndrome. Science 2004; 303(5665):1796-1799. (Pubitemid 38374862)
14. Cherezov V, Rosenbaum D, Hanson MA et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007; 318(5854):1258-1265. (Pubitemid 350172884)
15. Rosenbaum D, Cherezov V, Hanson MA et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007; 318(5854):1266-1273. (Pubitemid 350172885)
16. Rasmussen S, Choi H, Rosenbaum D et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007; 450(7168):383-387. (Pubitemid 350126755)
17. Hill SJ, Ganellin CR, Timmerman H et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 1997; 49(3):253-278. (Pubitemid 27414915)
18. Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol 2000; 105(6 Pt 2):S622-S627. (Pubitemid 30399797)
19. Elz S, Kramer K, Leschke C et al. Ring-substituted histaprodifen analogues as partial agonists for histamine H(1) receptors: Synthesis and structure-activity relationships. Eur J Med Chem 2000; 35(1):41-52. (Pubitemid 30136687)
20. Elz S, Kramer K, Pertz HH et al. Histaprodifens: Synthesis, pharmacological in vitro evaluation and molecular modeling of a new class of highly active and selective histamine H(1)-receptor agonists. J Med Chem 2000; 43(6):1071-1084. (Pubitemid 30173733)
21. Malinowska B, Piszcz J, Schlicker E et al. Histaprodifen, methylhistaprodifen and dimethylhistaprodifen are potent H1-receptor agonists in the pithed and in the anaesthetized rat. Naunyn Schmiedebergs Arch Pharmacol 1999; 359(1):11-16. (Pubitemid 29142563)
22. Menghin S, Pertz HH, Kramer K et al. N(alpha)-imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: Synthesis and in vitro evaluation of highly potent histamine H(1)-receptor agonists. J Med Chem 2003; 46(25):5458-5470. (Pubitemid 37490378)
23. Carman-Kržan M, Bavec A, Zorko M et al. Molecular characterization of specific H1-receptor agonists histaprodifen and its Nβ-substituted analogues on bovine aortic H1-receptors. Naunyn Schmiedebergs Arch Pharmacol 2003; 367(5):538-546. (Pubitemid 36718306)
24. Bakker RA, Weiner DM, ter Laak T et al. 8R-lisuride is a potent stereospecific histamine H1-receptor partial agonist. Mol Pharmacol 2004; 65(3):538-549. (Pubitemid 38264021)
25. Yamashita M, Fukui H, Sugama K et al. Expression cloning of a cDNA encoding the bovine histamine H1 receptor. Proc Natl Acad Sci U S A 1991; 88(24):11515-11519. (Pubitemid 21916072)
26. De Backer MD, Gommeren W, Moereels H et al. Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor. Biochem Biophys Res Commun 1993; 197(3):1601-1608. (Pubitemid 24042807)
27. Fukui H, Fujimoto K, Mizuguchi H et al. Molecular cloning of the human histamine H1 receptor gene. Biochem Biophys Res Commun 1994; 201(2):894-901. (Pubitemid 24206956)
28. Moguilevsky N, Varsalona F, Noyer M et al. Stable expression of human H1-histamine-receptor cDNA in Chinese hamster ovary cells. Pharmacological characterisation of the protein, tissue distribution of messenger RNA and chromosomal localisation of the gene. Eur J Biochem/FEBS 1994; 224(2):489-495. (Pubitemid 24282832)
29. De Backer MD, Loonen I, Verhasselt P et al. Structure of the human histamine H1 receptor gene. Biochem J 1998; 335( Pt 3):663-670. (Pubitemid 28515422)
30. Leopoldt D, Harteneck C, Nurnberg B. G proteins endogenously expressed in Sf 9 cells: Interactions with mammalian histamine receptors. Naunyn Schmiedebergs Arch Pharmacol 1997; 356(2):216-224. (Pubitemid 27341977)
31. Bakker RA, Wieland K, Timmerman H et al. Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists. Eur J Pharmacol 2000; 387(1):R5-R7. (Pubitemid 30035384)
32. Bakker RA, Schoonus SB, Smit MJ et al. Histamine H(1)-receptor activation of nuclear factor-kappa B: Roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 2001; 60(5):1133-1142. (Pubitemid 33027449)
33. Lim HD, van Rijn RM, Ling P et al. Evaluation of histamine H1-, H2- and H3-receptor ligands at the human histamine H4 receptor: Identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 2005; 314(3):1310-1321. (Pubitemid 41205997)
34. Deakin M, Williams JG. Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers. Drugs 1992; 44(5):709-719.
35. Freston JW. Management of peptic ulcers: Emerging issues. World J Surg 2000; 24(3):250-255. (Pubitemid 30117750)
36. Penston JG. Review article: Clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Aliment Pharmacol Ther 1996; 10(4):469-486. (Pubitemid 26254791)
37. Eriks JC, van der Goot H, Sterk GJ et al. Histamine H2-receptor agonists. Synthesis, in vitro pharmacology and qualitative structure-activity relationships of substituted 4- and 5-(2-aminoethyl)thiazoles. J Med Chem 1992; 35(17):3239-3246.
38. Gantz I, Schaffer M, DelValle J et al. Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci U S A 1991; 88(2):429-433. (Pubitemid 21915478)
39. Gantz I, Munzert G, Tashiro T et al. Molecular cloning of the human histamine H2 receptor. Biochem Biophys Res Commun 1991; 178(3):1386-1392.
40. Kuhn B, Schmid A, Harteneck C et al. G proteins of the Gq family couple the H2 histamine receptor to phospholipase C. Mol Endocrinol 1996; 10(12):1697-1707. (Pubitemid 26408757)
41. Smit MJ, Leurs R, Alewijnse AE et al. Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors. Proc Natl Acad Sci U S A 1996; 93(13):6802-6807. (Pubitemid 26230391)
42. Alewijnse AE, Smit MJ, Hoffmann M et al. Constitutive activity and structural instability of the wild-type human H2 receptor. J Neurochem 1998; 71(2):799-807. (Pubitemid 28480429)
43. Schwartz JC, Arrang JM, Garbarg M et al. Plenary lecture. A third histamine receptor subtype: Characterisation, localisation and functions of the H3-receptor. Agents Actions 1990; 30(1-2):13-23. (Pubitemid 20142230)
44. Bertaccini G, Coruzzi G. An update on histamine H3 receptors and gastrointestinal functions. Dig Dis Sci 1995; 40(9):2052-2063.
45. Malinowska B, Godlewski G, Schlicker E. Histamine H3 receptors-general characterization and their function in the cardiovascular system. J Physiol Pharmacol 1998; 49(2):191-211. (Pubitemid 28331405)
46. Delaunois A, Gustin P, Garbarg M et al. Modulation of acetylcholine, capsaicin and substance P effects by histamine H3 receptors in isolated perfused rabbit lungs. Eur J Pharmacol 1995; 277(2-3):243-250.
47. Alguacil LF, Perez-Garcia C. Histamine H3 receptor: A potential drug target for the treatment of central nervous system disorders. Curr Drug Targets 2003; 2(5):303-313.
48. Bonaventure P, Letavic M, Dugovic C et al. Histamine H3 receptor antagonists: From target identification to drug leads. Biochem Pharmacol 2007; 73(8):1084-1096. (Pubitemid 46413171)
49. Hancock AA. The challenge of drug discovery of a GPCR target: Analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists. Biochem Pharmacol 2006; 71(8):1103-1113. (Pubitemid 43361919)
50. Leurs R, Bakker RA, Timmerman H et al. The histamine H3 receptor: From gene cloning to H3 receptor drugs. Nat Rev Drug Discov 2005; 4(2):107-120. (Pubitemid 40277492)
51. Leurs R, Timmerman H. The histamine H3-receptor: A target for developing new drugs. Progress in drug research. Fortschr Arzneimittelforsch 1992; 39:127-165.
52. Hancock AA, Fox GB. Perspectives on cognitive domains, H3 receptor ligands and neurological disease. Expert Opin Investig Drugs 2004; 13(10):1237-1248. (Pubitemid 39359655)
53. Caulfield MP, Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998; 50(2):279-290. (Pubitemid 28304029)
54. Missale C, Nash SR, Robinson SW et al. Dopamine receptors: From structure to function. Physiol Rev 1998; 78(1):189-225. (Pubitemid 28070979)
55. Schlicker E, Malinowska B, Kathmann M et al. Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fundam Clin Pharmacol 1994; 8(2):128-137. (Pubitemid 24103046)
56. Schwartz JC, Arrang JM, Garbarg M et al. Histaminergic transmission in the mammalian brain. Physiol Rev 1991; 71(1):1-51.
57. Wijtmans M, Leurs R, de Esch I. Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas. Expert Opin Investig Drugs 2007; 16(7):967-985. (Pubitemid 47074155)
58. Passani MB, Lin JS, Hancock A et al. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci 2004; 25(12):618-625. (Pubitemid 39458167)
59. van der Goot H, Schepers MJP, Sterk GJ et al. Isothiourea analogues of histamine as potent agonists or antagonists of the histamine H3-receptor. Eur J Med Chem 1992; 27(5):511-517.
60. Cowart M, Altenbach R, Black L et al. Medicinal chemistry and biological properties of non-imidazole histamine H3 antagonists. Mini Rev Med Chem 2004; 4(9):979-992. (Pubitemid 39406257)
61. LaBella FS, Queen G, Glavin G et al. H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450. Br J Pharmacol 1992; 107(1):161-164.
62. Yang R, Hey JA, Aslanian R et al. Coordination of histamine H3 receptor antagonists with human adrenal cytochrome P450 enzymes. Pharmacology 2002; 66(3):128-135. (Pubitemid 35316924)
63. Arrang JM, Garbarg M, Lancelot JC et al. Highly potent and selective ligands for a new class H3 of histamine receptor. Invest Radiol 1988; 23 Suppl 1:S130-S132.
64. Kitbunnadaj R, Zuiderveld OP, Christophe B et al. Identification of 4-(1H-imidazol-4(5)-ylmethyl) pyridine (immethridine) as a novel, potent and highly selective histamine H(3) receptor agonist. J Med Chem 2004; 47(10):2414-2417. (Pubitemid 38580078)
65. Lovenberg TW, Roland BL, Wilson SJ et al. Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 1999; 55(6):1101-1107. (Pubitemid 29252378)
66. Hancock AA, Esbenshade TA, Krueger KM et al. Genetic and pharmacological aspects of histamine H3 receptor heterogeneity. Life Sci 2003; 73(24):3043-3072. (Pubitemid 37205140)
67. Drutel G, Peitsaro N, Karlstedt K et al. Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 2001; 59(1):1-8. (Pubitemid 32043078)
68. Clark EA, Hill SJ. Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin. Eur J Pharmacol 1996; 296(2):223-225.
69. Wieland K, Bongers G, Yamamoto Y et al. Constitutive activity of histamine H(3) receptors stably expressed in SK-N-MC cells: Display of agonism and inverse agonism by H(3) antagonists. J Pharmacol Exp Ther 2001; 299(3):908-914. (Pubitemid 33104958)
70. Morisset S, Rouleau A, Ligneau X et al. High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 2000; 408(6814):860-864. (Pubitemid 32016096)
71. Uveges AJ, Kowal D, Zhang Y et al. The role of transmembrane helix 5 in agonist binding to the human H3 receptor. J Pharmacol Exp Ther 2002; 301(2):451-458. (Pubitemid 34429954)
72. Cogé F, Guenin SP, Audinot V et al. Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochem J 2001; 355(Pt 2):279-288. (Pubitemid 32397785)
73. Gomez-Ramirez J, Ortiz J, Blanco I. Presynaptic H3 autoreceptors modulate histamine synthesis through cAMP pathway. Mol Pharmacol 2002; 61(1):239-245. (Pubitemid 34049532)
74. Sanchez-Lemus E, Arias-Montano JA. Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices. Neurosci Lett 2004; 364(3):179-184. (Pubitemid 38757928)
75. Bakker RA, Lozada AF, van Marle A et al. Discovery of naturally occurring splice variants of the rat histamine H3 receptor that act as dominant-negative isoforms. Mol Pharmacol 2006; 69(4):1194-1206.
76. Bongers G, Sallmen T, Passani MB et al. The Akt/GSK-3beta axis as a new signaling pathway of the histamine H(3) receptor. J Neurochem 2007; 103(1):248-258. (Pubitemid 47404216)
77. Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: The search for new antihistamines. Nat Rev Drug Discov 2008; 7(1):41-53.
78. Jablonowski JA, Grice CA, Chai W et al. The first potent and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem 2003; 46(19):3957-3960. (Pubitemid 37122442)
79. Liu C, Wilson SJ, Kuei C et al. Comparison of human, mouse, rat and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther 2001; 299(1):121-130. (Pubitemid 32905126)
80. Lim HD, Smits RA, Bakker RA et al. Discovery of S-(2-guanidylethyl)- isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist. J Med Chem 2006; 49(23):6650-6651. (Pubitemid 44749731)
81. Thurmond RL, Desai PJ, Dunford PJ et al. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther Apr 2004; 309(1):404-413. (Pubitemid 38393154)
82. Coruzzi G, Adami M, Guaita E et al. Anti-inflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. Eur J Pharmacol 2007; 563(1-3):240-244. (Pubitemid 46602245)
83. Zhang M, Thurmond RL, Dunford PJ. The histamine H(4) receptor: A novel modulator of inflammatory and immune disorders. Pharmacol Ther 2007; 113(3):594-606. (Pubitemid 46371410)
84. de Esch IJ, Thurmond RL, Jongejan A et al. The histamine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci 2005; 26(9):462-469. (Pubitemid 41207878)
85. Coge F, Guenin SP, Rique H et al. Structure and expression of the human histamine H4-receptor gene. Biochem Biophys Res Commun 2001; 284(2):301-309. (Pubitemid 32917975)
86. Nakamura T, Itadani H, Hidaka Y et al. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 2000; 279(2):615-620. (Pubitemid 32016763)
87. Hofstra CL, Desai PJ, Thurmond RL et al. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 2003; 305(3):1212-1221. (Pubitemid 36618001)
88. Nakayama T, Kato Y, Hieshima K et al. Liver-expressed chemokine/CC chemokine ligand 16 attracts eosinophils by interacting with histamine H4 receptor. J Immunol 2004; 173(3):2078-2083. (Pubitemid 38971645)